1.4 Update Management HIV Dalam Kehamilan
1.4 Update Management HIV Dalam Kehamilan
dalam Kehamilan
Dr. BUDI PRASETYO, dr., SpOG(K)
Kegiatan Komprehensif
1. Mencegah terjadinya penularan HIV pada
perempuan usia reproduksi
2. Mencegah kehamilan yang tidak direncanakan
pada ibu dengan HIV
3. Mencegah terjadinya penularan HIV dari ibu
hamil dengan HIV ke bayi yang dikandungnya
4. Memberikan dukungan psikologis, sosial dan
perawatan kepada ibu dengan HIV beserta bayi
& keluarganya
WHO
4 Prong
1 2 3
4
Mazami Enterprise © 2009
1. Mencegah terjadinya penularan HIV pada
perempuan usia reproduksi
1 2
1 2 3
4
Mazami Enterprise © 2009
UPDATE?
KEBIJAKAN
SKRINING
ARV
MODE OF
DELIVERY
Pedoman
Pedoman Nasional Penanganan Infeksi Menular Seksual, 2011
Pedoman Penerapan Layanan Komprehensif HIV-IMS Berkesinambungan,
2012
Pedoman Tatalaksana Sifilis untuk Pengendalian IMS di Layanan Kesehatan
Dasar, 2013
Pedoman Pemantauan Pencapaian Akses Universal Kesehatan Reproduksi
(Universal Access To Reproductive Health) Di Tingkat Nasional, &
Kabupaten/Kota Di Indonesia, 2013
Pedoman Pengobatan Antiretroviral, 2014
Pedoman Pelaksanaan Pencegahan Penularan HIV dan Sifilis dari Ibu Ke
Anak Bagi Tenaga Kesehatan, 2014
Pedoman Penerapan Terapi HIV pada Anak, 2014
Pedoman Penyelenggaraan Pemeriksaan Laboratorium untuk Ibu Hamil,
Bersalin, dan Nifas Di Fasilitas Pelayanan Kesehatan Dan Jaringan
Pelayanannya, 2015
PEDOMAN PELAKSAAN PENCEGAHAN PENULARAN HIV DAN SIFILIS DARI IBU
KE ANAK BAGI NAKES, KEMENKES 2015
TAWARKANN
TES ULANG SAAT
KUINJUNGAN
ULANG
KONSELING DAN
TES SUKARELA
(KTS)
PEDOMAN PELAKSAAN PENCEGAHAN PENULARAN HIV
DAN SIFILIS DARI IBU KE ANAK BAGI NAKES, KEMENKES
2015
ARV
Earlier ART initiation a lower risk of perinatal transmission
. A study of 8075 women who received antepartum ART in
France between 2000 and 2011 found an overall rate of
transmission of 0.7 percent; no transmission occurred
among 2651 infants born to women who received ART
before conception, continued ART throughout pregnancy,
and had a viral load <50 copies/mL at delivery.
Regardless of viral load, the transmission rate increased
from 0.2 percent for women receiving ART before
conception to 0.4, 0.9, and 2.2 percent for women initiating
ART in the first, second, or third trimester.
in a study of 519 treatment-naïve pregnant women
initiating ART, 93 percent had achieved a HIV viral level
<400 copies/mL by the third month of therapy
Brenna Hughes, et al. Antiretroviral treatment of pregnant HIV-
infected women and antiretroviral prophylaxis of their infants in
resource-rich settings. Uptodate, 2016
Perinatal HIV infection can occur during pregnancy,
labor and delivery, or during the breastfeeding period.
However, with appropriate ART and effective viral
suppression, the risk of an infant becoming infected
via perinatal transmission is now estimated to be less
than 1 to 2 percent in the United States and Europe
More recent data suggests that earlier initiation of
ART is associated with decreased transmission, with
some suggestion that the lowest risk may be among
women entering pregnancy virally suppressed.
All HIV-infected pregnant women should receive ART
to prevent mother-to-child transmission of HIV,
regardless of their CD4 cell counts or HIV RNA levels
In a study of 8075 HIV-infected women who received
antepartum ART in France between 2000 and 2011, the
odds of perinatal transmission were fourfold higher
(95% CI 1.9-8.2) for women with a viral load of 50 to
400 copies/mL at delivery compared to those with a
viral load <50 copies/mL (1.5 percent when a viral load
was 50 to 400 copies/mL versus 0.3 percent when a
delivery viral load was <50 copies/mL) [8]. The
transmission rate was 2.8 percent among women with a
viral load >400 copies/mL.
the NRTI backbone — Because of its extensive safety
profile and long history of use in pregnancy :
zidovudine-lamivudine (ZDV/3TC) as the combination
NRTI backbone.
PROTOKOL PEMBERIAN ARV
2 NRTI +1 NNRTI
ARV KOMBINASI DOSIS TETAP : TDF
(300MG) + 3TC (300MG) + EFV (600MG)
ALTERNATIF:
AZT (2X300MG) + 3TC(2X150MG) +NVP
(1X200MG 2X200MG)
TDF + 3TC+ NVP
AZT+3TC+EFV